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Background: Dogs are commonly affected by hyperglycemic conditions. Hyperglycemia compromises the immune
response and favors bacterial infections; however, reports on the effects of glucose on neutrophil oxidative
metabolism and apoptosis are conflicting in humans and rare in dogs. Considering the many complex factors that
affect neutrophil oxidative metabolism in vivo, we investigated in vitro the specific effect of high concentrations of
glucose on superoxide production and apoptosis rate in neutrophils from healthy dogs.
Results: The capacity of the neutrophils to reduce tetrazolium nitroblue decreased significantly in the higher
concentration of glucose (15.13 ± 9.73% (8 mmol/L) versus 8.93 ± 5.71% (16 mmol/L)). However, there were no
changes in tetrazolium nitroblue reduction at different glucose concentrations when the neutrophils were first
activated with phorbol myristate acetate. High concentrations of glucose did not affect the viability and apoptosis
rate of canine neutrophils either with or without prior camptothecin stimulation. This study provides the first
evidence that high concentrations of glucose inhibit the oxidative metabolism of canine neutrophils in vitro in a
manner similar to that which occurs in humans, and that the decrease in superoxide production did not increase
the apoptosis rate.
Conclusions: A high concentration of glucose reduces the oxidative metabolism of canine neutrophils in vitro. It is
likely that glucose at high concentrations rapidly affects membrane receptors responsible for the activation of
NADPH oxidase in neutrophils; therefore, the nonspecific immune response can be compromised in dogs with
acute and chronic hyperglycemic conditions.
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Hyperglycemia occurs frequently in critically ill dogs
hospitalized in intensive care units (16%), and their
morbidity is directly associated with their blood glucose
concentration [1]. In humans, functional defects in neu-
trophils that diminish the microbicidal and phagocytic
function of the cells and increase the risk of bacterial
infection are attributed to hyperglycemia [2]. The mo-
lecular, biochemical and cellular basis of this decrease in
immunological defense is not well understood in
humans [3], and the relationship between hyperglycemia
and neutrophil dysfunction in dogs remains to be ad-
equately investigated.* Correspondence: anebosco@hotmail.com
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reproduction in any medium, provided the orReactive oxygen species (ROS), including superoxide
anion and its derivatives, exert an important bactericidal
function in neutrophils and are components of some of
the conditions associated with the pathogenesis of
diabetes [4]. However, the effect of hyperglycemia on
neutrophil production of ROS is unclear. Some studies
have reported increased ROS production in diabetic
patients [5,6,7], and in healthy patients that underwent a
hyperglycemic challenge [8]. The reduction of the neu-
trophil oxidative burst in patients with poorly controlled
diabetes mellitus has also been described [9], but such
alteration did not occur in patients with experimentally
varied concentrations of blood glucose [10] and with
acute, induced hyperglycemia [11].
There are many complex factors affecting the neutro-
phil respiratory burst in vivo, and different concentra-
tions of blood glucose in patients can also affect the
oxidative metabolism of neutrophils. Thus, to minimizetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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an adequate understanding of how glucose concentrations
can affect the oxidative metabolism of neutrophils. Neutro-
phils from healthy individuals, when incubated with high
concentrations of glucose in vitro, have lower superoxide
anion production [12,2,13]. In humans, the in vitro inhib-
ition of neutrophil oxidative metabolism seems to be
dependent on glucose concentration. Perner et al. [14]
incubated neutrophils from healthy patients in solutions
containing 5 mmol/L, 10 mmol/L and 25 mmol/L of glu-
cose and verified 50% inhibition of superoxide production
in the highest glucose concentration.
Nielson et al. [12] suggest that the suppressing effect
of glucose on the oxidative metabolism of neutrophils is
due to protein glycosylation. Monosaccharides such as
glucose, mannose and fructose form Schiff-base adducts
with proteins, which cause inhibition of neutrophil func-
tion. Four mechanisms underlie the oxidative stress
associated with hyperglycemia: increased polyol pathway
flux, increased advanced glycation end product (AGE)
formation, activation of protein kinase C (PKC) iso-
forms, and increased hexosamine pathway flux [15].
There is evidence that oxidative stress in diabetics
increases apoptosis of neurons [16], endothelial cells
[17], pancreatic cells [18], mesangial cells [19], and renal
podocytes [20]. However, the relationship between
hyperglycemia and neutrophil viability needs further
study. According to Tennenberg et al. [21], high concen-
trations of blood glucose decrease the functional longev-
ity of human neutrophils and increase neutrophil
clearance from infected sites, possibly contributing to
the increased susceptibility to and severity of infections
in diabetic patients. In contrast, Turina et al. [22]
observed no alteration in human neutrophil apoptosis
when exposed to high concentrations of plasma glucose.
In diabetic rats, the glycolytic metabolism and the
protector effect of glutamine on neutrophils is altered,
accelerating apoptosis and increasing susceptibility to
infections [23].
Although dogs are commonly affected by diabetic
hyperglycemia and are considered the best animal model
for the study of human diabetes [23], there are few stud-
ies examining the effect of glucose on neutrophil oxida-
tive metabolism and apoptosis in dogs. The decrease in
NADPH oxidase activity seen in the neutrophils of dogs
fed high levels of galactose results from excessive
consumption of enzyme due to increased polyol pathway
activity [24]. In this circumstance, excessive consump-
tion of NADPH decreases superoxide production and
compromises the bactericidal function of neutrophils. A
diabetic retinopathy, similar to that which occurs in
humans, was induced in dogs fed a 30% galactose diet.
When isolated neutrophils from healthy dogs were incu-
bated with a similar concentration of galactose there wasno alteration in their apoptosis rate; however, in vivo
evaluation of neutrophils revealed a lower apoptosis rate
and higher adhesion in galactose-fed dogs [25].
In vitro studies are necessary to evaluate the specific
effects of glucose on neutrophil oxidative metabolism
and apoptosis, especially in diabetic dogs and hypergly-
cemic conditions. The aim of this study was to test,
in vitro, whether high concentrations of glucose inhibit
the oxidative metabolism of isolated neutrophils from
healthy dogs, and also to evaluate the viability and apop-
tosis rate of these cells when incubated in different
concentrations of glucose.
Results
A high glucose concentration inhibits the oxidative
metabolism of canine neutrophils
The interference of glucose with the oxidative metabol-
ism of human neutrophils has been described [2,12,14].
This interference was evaluated in dogs using the NBT
reduction test to quantify the superoxide production of
neutrophils from healthy dogs in RPMI medium con-
taining a high concentration of glucose.
Neutrophils incubated in pure RPMI medium reduced
significantly more NBT than neutrophils incubated in
RPMI with a high concentration of glucose (15.13 ±
9.73% (8 mmol/L) versus 8.93 ± 5.71% (16 mmol/L)).
Thus, similar to the effects seen in human neutrophils
in vitro [14], superoxide production decreased in canine
neutrophils in the presence of a high concentration of
glucose. However, no inhibitory effects on neutrophil
oxidative metabolism were observed when the cells had
been previously activated with PMA (Table 1).
Maintenance of neutrophil viability during incubation
with a high concentration of glucose
We compared the viability and apoptosis rate of neutro-
phils isolated from healthy dogs and incubated in pure
RPMI media or in RPMI media with addition of glucose.
The protocol for neutrophil isolation and incubation in
RPMI media did not compromise cell viability, even
though the glucose concentration of RPMI media is
8 mmol/L, which is higher than that of normal dog
plasma (4–6 mmol/L) (Table 2). When apoptosis was sti-
mulated with CAM, there was a decrease in viability
associated with increased neutrophil apoptosis in both
the pure and the glucose-enriched media. RPMI
enriched with glucose resulted in a numerical increase
in the apoptosis rate; however, this difference was not
statistically significant.
Discussion
Multiple cellular factors have been associated with
neutrophil dysfunction in hyperglycemic conditions.
These include nicotinamide [9], protein components of
Table 1 Oxidative metabolism of neutrophils from
healthy dogs at two different concentrations of glucose
Glucose
concentration
Percentage of neutrophils reducing NBT
Spontaneous PMA activation
8 mmol/L 15.13 ± 9.73a 73.66 ± 8.52a
16 mmol/L 8.93 ± 5.71b 72.20 ± 9.71a
p-value 0.0304 0.6444
* Different letters in the same column indicate a statistically significant
difference.
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chemokines [28], expression of pro-inflammatory genes
[11], and alterations in several different mechanisms of
cellular activation as well as modifications of proteins
and lipids [29]. However, the complete mechanism
underlying glucose-associated neutrophil dysfunction is
still unknown.
In this study, we verified in vitro that neutrophils of
healthy dogs decrease superoxide production when incu-
bated in a high concentration of glucose (16 mmol/L).
Similar results were observed in human neutrophils
incubated with elevated concentrations of glucose such
as ≥11 mmol/L [12], ≥ 13.8 mmol/L [2] and 25 mmol/L
[14]. These results reinforce the affirmation of Ionut
et al. (2010) [30] that the dog is the most suitable model
for the study of human diabetes.
The in vitro inhibitory effect of glucose on the oxi-
dative metabolism of canine neutrophils has also
been observed in humans in vivo [9]; however, some
studies did not find alterations in the oxidative me-
tabolism of diabetic patients [10,11], while others
found increased oxidative metabolism [8,5,6,7]. This
discrepancy among the results of studies that evalu-
ated neutrophil oxidative metabolism may be due to
the heterogeneity of their protocols; different con-
centrations of glucose were used, various stimuli
were used to activate the cells, and oxidative metab-
olism was assessed by different methods [3]. Al-
though the NBT method is not able to determine the
precise concentration of superoxide produced, in this study
and in others [31,32,33,34] it was possible to assess neutro-
phil oxidative metabolism using this method.
Neutrophil activation occurs by a variety of distinct











8 mmol/L 97.93 ± 2.44 0.19 ± 0.19 0.19 ± 0.12 0.38 ±
16 mmol/L 97.76 ± 1.90 0.22 ± 0.23 0.26 ± 0.24 0.49 ±
p-value 0.8221 0.6812 0.4202 0.3activators depend on complement (calcium ionophore
A23187), while others require opsonization (zymosan)
and others, such as N-formyl-methionine-leucine-
phenylalanine (fMLP), depend on specific protein
receptors [35]. In this study, the potent neutrophil ac-
tivator PMA was used. PMA does not require recep-
tors to activate NADPH oxidase, instead inducing
superoxide production directly by protein kinase C
activation [36]. According to Mcmanus et al. (2001)
[3], in diabetic patients neutrophil activation occurs
only in the presence of stimuli that initiate signal
transduction via G-protein coupled receptors, thus it
does not occur in the presence of PMA. This may
explain why excessive glucose in the media did not
alter the oxidative metabolism of neutrophils acti-
vated with PMA, and suggests that the inhibition of
oxidative metabolism observed in the trials without
PMA is due to a failure in G-protein coupled signal
transduction, which is responsible for NADPH oxi-
dase activation.
There is evidence that a high concentration of glucose
decreases neutrophil functional longevity in humans and
increases neutrophil clearance from infected sites, possibly
contributing to the increased susceptibility to and severity
of infections in diabetic patients [21]. The mechanisms
related to the acceleration of apoptosis during hypergly-
cemia are associated with decreased resistance to oxidative
stress, increases in protein glycosylation, and decreased
protective effect of glutamine [23].
Oxidative stress associated with short-term hyper-
glycemia increases the apoptosis rate of neurons [16]
and renal podocytes [20]. Conversely in our study,
neutrophils maintained for a short period (4 h) in
glucose-rich media did not have an increased apop-
tosis rate. Similar results were observed in human
neutrophils incubated for 24 h with high (100 mg/dL)
and low (10 mg/dL) concentrations of glucose [22].
Similarly, no acceleration of neutrophil apoptosis was
observed in diabetes-induced dogs [25] and rats [37].
Therefore, it is reasonable to assume that the varying
results regarding the assessment of neutrophil apop-
tosis in short-period experiments are due to a pro-
apoptotic effect of glucose that only occurs in conditions











0.23 69.91 ± 15.34 5.87 ± 4.77 19.16 ± 13.09 25.04 ± 14.60
0.43 67.73 ± 12.31 6.54 ± 5.72 22.21 ± 15.04 28.76 ± 12.66
593 0.6508 0.7132 0.5327 0.4332
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This study provides the first evidence that high concen-
trations of glucose inhibit the oxidative metabolism of
canine neutrophils in vitro, and that this inhibition does
not alter the apoptosis rate and viability of the neutro-
phils. High concentrations of glucose may rapidly affect
the membrane receptors responsible for the activa-
tion of NADPH oxidase; in this way even short-term
hyperglycemia can compromise the oxidative metab-
olism of canine neutrophils. However, further inves-
tigations are required to evaluate the clinical
implications of these results.Methods
Animal selection
Seventeen adult mongrel dogs of both sexes were used.
Only dogs with no abnormalities on physical examin-
ation and laboratory tests (hemogram, plasma fibrino-
gen, urinalysis, plasma albumin, urea, creatinine, uric
acid, cholesterol, glucose, and fructosamine) were
included. The region is endemic for leishmaniasis, and
dogs were selected for the study only after negative sero-
logical testing. No animal that had recently received
treatment with any drug was included in the experiment.
The study was approved by the Animal Experimentation
Ethics Committee of the Faculty of Veterinary Medicine
of São Paulo State University and samples were obtained
with the consent of the owners.
Samples collection and maintenance
Whole blood samples were collected using disposable
needles and syringes and kept in heparinized sterile glass
tubes with 10 U of heparin (Vacutainer plus plastic
Heparin, Cod. 367993, Becton-Dickson, New Jersey,
USA) per 1 mL of whole blood. All the samples were
protected from light and kept at 4°C for a maximum
period of 2 h before analysis. Urine samples were
collected by cystocentesis and were also kept at 4°C and
protected from light until analysis.
Biochemical analyses, hemogram and urinalysis
All biochemical tests were performed using commercial
reagents (BioSystems Reagents, Barcelona, Spain) at 37°C
in an automated analyzer (Automatic Analyzer BTS, Mod.
370 plus, BioSystems) that had been previously calibrated
with a commercial calibrator, and reaction quality was
monitored with control levels I and II (Biosystems,
Barcelona, Spain). Plasma urea concentration was deter-
mined using the urease/glutamate dehydrogenase-coupled
UV enzymatic assay, creatinine using the alkaline picrate
kinetic assay, albumin using the bromocresol green assay,
uric acid using the uricase/peroxidase enzymatic assay,
cholesterol and glucose by the enzymatic oxidase/peroxidase method, and fructosamine by the colorimetric
method of NBT reduction.
White blood cell counts were performed in an automated
veterinary blood cell counter (Veterinary hematological
electronic cell counter, Mod. CC-530, CELM, São Paulo,
Brazil). Differential white cell counts were accomplished
using optical microscopy by the differentiation of 100 white
cells in a blood smear stained with panoptic dye (Instant-
Prov, Newprov, Pinhais-PR). Plasma fibrinogen was esti-
mated indirectly by refractometry (Refratometre ATAGOW
SPR-T2, ATAGO Co., LTD, Japan) using the heat precipita-
tion method (56 – 58°C).
Urinalysis was performed as described by Osborne
et al. (1995) [38] using commercial reagent strips for
chemical analysis (Combur 10 testW, Roche, Mannheim,
Germany) and refractometry for density determination.
Neutrophil isolation
A double gradient separation technique was used to
isolate neutrophils. Four mL of heparinized whole blood
(10 IU/mL) were transferred to sterile polypropylene
conical tubes containing equal volumes (3 mL) of
Histopaque-1119 and 1077 (Sigma, St. Louis, MO,
USA). Following centrifugation at 340 G for 30 min, the
layer of polymorphonuclear (PMN) cells was aspirated
and washed twice with aqueous ammonium chloride
(0.14 M) to ensure complete lysis of the residual ery-
throcytes. Next, the sample was centrifuged (100 G) for
5 min in Hanks' balanced salt solution (HBSS) (Sigma)
without Ca2+ and Mg2+ and 1 mL of RPMI media
(Sigma) was added to the cell sediment. Cell concentra-
tion was determined in a hemocytometer and cell viabil-
ity was estimated by the blue trypan dye exclusion
method. The sample of isolated PMNs was diluted in
RPMI to obtain a final cell concentration of 106 mL,
with the purity and viability of neutrophils equal to or
more than 90 and 95%, respectively.
Determination of neutrophil superoxide production
Neutrophil superoxide production was estimated by the
nitroblue tetrazolium (NBT) reduction test. Briefly, 100 μL
of the neutrophil suspension (106/mL) was incubated in
two sterile microtubes with 50 μL of 0.2% NBT solution in
saline. For the stimulated test, 1 μL (535 μmol/L) of PMA
(Phorbol 12-myristate 13-acetate, Cat. P8139, Sigma) was
added. After incubation in a thermal shaker at 37°C for 10
min, the samples were cytocentrifuged at 400 G for 5 min
and then stained with panoptic dye. The percentage of
positive cells was assessed by counting 100 cells.
Determining the viability and apoptotic index of the
neutrophils
The percentage of apoptotic cells and viable neutrophils
was determined using the Annexin V-PE assay Kit
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procedure for each test and proper instrument perform-
ance were verified in accordance with the manufacturer’s
recommendations. Briefly, two samples of 100 μL of neu-
trophils (106/mL) suspended in RPMI were incubated at
37°C for 1 h with 100 μL of RPMI medium (CAM absent)
and with 100 μL of camptothecin (19.8 mmol/L, Sigma).
Following incubation, 100 μL of each sample was trans-
ferred to a microtube with 100 μL of annexin V-PE reagent
and incubated in the dark at room temperature for 10 min.
In a capillary flow cytometer EasyCyte miniW (Guava,
Hayward, CA) 10,000 events were acquired, and viable,
apoptotic populations of neutrophils were delineated using
a specific computer program (Software Express PlusW
Guava, Hayward, CA).
In vitro experimental design to test the hypothesis that
glucose alters the oxidative metabolism and apoptosis of
neutrophils from healthy dogs
Neutrophils were isolated from 17 healthy dogs and
incubated in RPMI with two different concentrations of
glucose (8 and 16 mmol/L). After 2 h of incubation, the
superoxide production and the apoptosis rate of the
neutrophils were evaluated in spontaneous and stimu-
lated trials as described above.
Statistical analysis
Statistical tests were performed after testing the distribu-
tions of the variables for normality (Kolmogorov-Smirnov
test). Differences between control and hyperglycemic
groups were assessed using paired t-tests, with P values of
≤0.05 considered significant. SAS software (SAS Institute
Inc., The SAS System, release 9.2., Cary: NC, 2008) was
used for all statistical analyses.
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